Use of Apps to Promote Childhood Vaccination: Systematic Review.

childhood vaccination immunization infant mobile apps mobile phone smartphone technology vaccination vaccination coverage

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
18 05 2020
Historique:
received: 10 12 2019
accepted: 22 03 2020
revised: 13 03 2020
entrez: 19 5 2020
pubmed: 19 5 2020
medline: 28 4 2021
Statut: epublish

Résumé

Vaccination is a critical step in reducing child mortality; however, vaccination rates have declined in many countries in recent years. This decrease has been associated with an increase in the outbreak of vaccine-preventable diseases. The potential for leveraging mobile platforms to promote vaccination coverage has been investigated in the development of numerous mobile apps. Although many are available for public use, there is little robust evaluation of these apps. This systematic review aimed to assess the effectiveness of apps supporting childhood vaccinations in improving vaccination uptake, knowledge, and decision making as well as the usability and user perceptions of these apps. PubMed, Excerpta Medica Database (EMBASE), Web of Science, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and Education Resources Information Center (ERIC) databases were systematically searched for studies published between 2008 and 2019 that evaluated childhood vaccination apps. Two authors screened and selected studies according to the inclusion and exclusion criteria. Data were extracted and analyzed, and the studies were assessed for risk of bias. A total of 28 studies evaluating 25 apps met the inclusion criteria and were included in this analysis. Overall, 9 studies assessed vaccination uptake, of which 4 reported significant benefits (P<.001 or P=.03) of the implementation of the app. Similarly, 4 studies indicated a significant (P≤.054) impact on knowledge and on vaccination decision making. Patient perceptions, usability, and acceptability were generally positive. The quality of the included studies was found to be moderate to poor, with many aspects of the methodology being unclear. There is little evidence to support the use of childhood vaccination apps to improve vaccination uptake, knowledge, or decision making. Further research is required to understand the dichotomous effects of vaccination-related information provision and the evaluation of these apps in larger, more robust studies. The methodology of studies must be reported more comprehensively to accurately assess the effectiveness of childhood vaccination apps and the risk of bias of studies. RR2-10.2196/16929.

Sections du résumé

BACKGROUND
Vaccination is a critical step in reducing child mortality; however, vaccination rates have declined in many countries in recent years. This decrease has been associated with an increase in the outbreak of vaccine-preventable diseases. The potential for leveraging mobile platforms to promote vaccination coverage has been investigated in the development of numerous mobile apps. Although many are available for public use, there is little robust evaluation of these apps.
OBJECTIVE
This systematic review aimed to assess the effectiveness of apps supporting childhood vaccinations in improving vaccination uptake, knowledge, and decision making as well as the usability and user perceptions of these apps.
METHODS
PubMed, Excerpta Medica Database (EMBASE), Web of Science, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and Education Resources Information Center (ERIC) databases were systematically searched for studies published between 2008 and 2019 that evaluated childhood vaccination apps. Two authors screened and selected studies according to the inclusion and exclusion criteria. Data were extracted and analyzed, and the studies were assessed for risk of bias.
RESULTS
A total of 28 studies evaluating 25 apps met the inclusion criteria and were included in this analysis. Overall, 9 studies assessed vaccination uptake, of which 4 reported significant benefits (P<.001 or P=.03) of the implementation of the app. Similarly, 4 studies indicated a significant (P≤.054) impact on knowledge and on vaccination decision making. Patient perceptions, usability, and acceptability were generally positive. The quality of the included studies was found to be moderate to poor, with many aspects of the methodology being unclear.
CONCLUSIONS
There is little evidence to support the use of childhood vaccination apps to improve vaccination uptake, knowledge, or decision making. Further research is required to understand the dichotomous effects of vaccination-related information provision and the evaluation of these apps in larger, more robust studies. The methodology of studies must be reported more comprehensively to accurately assess the effectiveness of childhood vaccination apps and the risk of bias of studies.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
RR2-10.2196/16929.

Identifiants

pubmed: 32421684
pii: v8i5e17371
doi: 10.2196/17371
pmc: PMC7265109
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17371

Informations de copyright

©Caroline de Cock, Michelle van Velthoven, Madison Milne-Ives, Mary Mooney, Edward Meinert. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 18.05.2020.

Références

Int J Equity Health. 2011 Jun 30;10:27
pubmed: 21718495
Hum Vaccin Immunother. 2016 Oct 2;12(10):2654-2661
pubmed: 27322109
Vaccine. 2015 Jun 9;33(25):2862-80
pubmed: 25944299
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
Hum Vaccin Immunother. 2017 May 4;13(5):1149-1154
pubmed: 28059610
Vaccine. 2019 Jan 7;37(2):272-279
pubmed: 30522907
NI 2012 (2012). 2012 Jun 23;2012:228
pubmed: 24199091
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
BMC Public Health. 2016 Aug 31;16:909
pubmed: 27581655
Pediatr Res. 2019 Jun;85(7):912-914
pubmed: 30812027
Eval Program Plann. 2017 Aug;63:1-6
pubmed: 28279866
MMWR Morb Mortal Wkly Rep. 2018 Oct 12;67(40):1123-1128
pubmed: 30307907
Ann Intern Med. 2015 Nov 17;163(10):806-7
pubmed: 26571249
Vaccine. 2019 Oct 8;37(43):6478-6485
pubmed: 31506192
Pediatrics. 2014 Apr;133(4):e835-42
pubmed: 24590751
Glob Health Res Policy. 2019 Mar 22;4:8
pubmed: 30949586
J Evid Based Med. 2017 Dec 21;:
pubmed: 29266844
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
JMIR Serious Games. 2019 Apr 08;7(2):e8540
pubmed: 30958271
Patient Educ Couns. 2017 Apr;100(4):736-741
pubmed: 27912928
Hum Vaccin Immunother. 2017 Nov 2;13(11):2512-2521
pubmed: 29125783
Front Psychol. 2018 Jun 13;9:735
pubmed: 29951010
JMIR Mhealth Uhealth. 2015 Jan 14;3(1):e4
pubmed: 25589367
BMC Med Inform Decis Mak. 2010 Nov 03;10:69
pubmed: 21047412
Pediatrics. 2016 Jul;138(1):
pubmed: 27296865
Vaccine. 2005 Apr 27;23(23):3010-5
pubmed: 15811647
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
J Telemed Telecare. 2014 Dec;20(8):476-80
pubmed: 25084770
JMIR Mhealth Uhealth. 2015 Feb 26;3(1):e20
pubmed: 25803705
J Infect Public Health. 2016 Nov - Dec;9(6):781-789
pubmed: 27659114
Vaccine. 2019 Jul 26;37(32):4594-4600
pubmed: 29699784
Int Arch Otorhinolaryngol. 2018 Jul;22(3):317-329
pubmed: 29983775
Prev Med Rep. 2017 Jan 14;5:241-250
pubmed: 28127527
Healthc Inform Res. 2018 Jul;24(3):207-226
pubmed: 30109154
J Low Genit Tract Dis. 2019 Jul;23(3):188-192
pubmed: 30973442
J Pediatr Health Care. 2014 Jan-Feb;28(1):35-42
pubmed: 23195652
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
BMJ. 2019 Jan 21;364:l312
pubmed: 30665901
BMJ Open. 2016 Dec 8;6(12):e011458
pubmed: 27932337
PLoS Med. 2019 Oct 24;16(10):e1002939
pubmed: 31647821
J Public Health (Oxf). 2017 Sep 1;39(3):e118-e126
pubmed: 27247122
Stud Health Technol Inform. 2019;257:17-23
pubmed: 30741166
Vaccine. 2016 Nov 4;34(46):5495-5503
pubmed: 27692772
Vaccine. 2016 Jan 4;34(2):276-283
pubmed: 26647290
J Med Syst. 2017 Nov 29;42(1):14
pubmed: 29188446
Pediatrics. 2008 Jan;121 Suppl 1:S46-54
pubmed: 18174320
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
JMIR Mhealth Uhealth. 2018 Mar 07;6(3):e59
pubmed: 29514772
J Pediatr Pharmacol Ther. 2016 Mar-Apr;21(2):104-9
pubmed: 27199617
Vaccine. 2015 Mar 30;33(14):1629-32
pubmed: 25704801
Health Policy Plan. 2015 Jun;30(5):638-44
pubmed: 24920218

Auteurs

Caroline de Cock (C)

Digitally Enabled PrevenTative Health Research Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Michelle van Velthoven (M)

Digitally Enabled PrevenTative Health Research Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Madison Milne-Ives (M)

Digitally Enabled PrevenTative Health Research Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Mary Mooney (M)

School of Nursing & Midwifery, Trinity College Dublin, Dublin, Ireland.

Edward Meinert (E)

Digitally Enabled PrevenTative Health Research Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Department of Primary Care and Public Health, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH